NR1H4 and metabolic disease: ,25 Moreover, metformin ameliorates metabolic disorders in part through inhibiting intestinal FXR signaling by reduction the proportion of BSH-producing bacteria, increasing conjugated BA, and acting as an FXR antagonist.26